Outcomes of Inpatient Chemotherapy for Patients with Newly Diagnosed Extensive-Stage Small-Cell Lung Cancer.

Median age was 68 years (range 50-87), 58% female, 99% had prior smoking history, 22% had brain metastases, and 64% had liver metastases.

Ninety-two (72%) received chemotherapy.

Patients in the non-treatment cohort had a median OS of 14 days (95% CI, 0.2-0.7 m), a median LOS of 11 days, and 54% in-hospital death rate.

Tumor lysis syndrome occurred in six of the 76 (8%) evaluated patients, all dying within 7 days of chemotherapy.